Using 340B drug discounts to provide a financially sustainable medication discharge service

The 340B Drug Pricing Program was intended to stretch federal resources by providing significant discounts to covered entities providing care to underserved populations. Program implementation and evidence of expanding services to higher income patients has brought more scrutiny and calls for elimination of the program. While additional review and reform may be warranted, profitability from 340B discounts enables covered entities to provide additional services that may not be feasible in absence of the program.

Source: Research in Social and Administrative Pharmacy - March 27, 2018 Category: Pharmaceuticals Authors: Timothy Wu, Carla Williams, Kathryn Vranek, T. Joseph Mattingly Source Type: research